The TruSight Tumor 170 bundle kits that contain NextSeq 500/550 v2 sequencing reagents (catalog numbers OP-101-1003 and 20018621) will be discontinued on August 30th, 2019 with a last ship date of November 29th, 2019.
The TruSight Tumor 170 Kit with NextSeq v2.5 Reagents (catalog number 20028821) is the recommended replacement product. Note that it does not include Watson for Genomics; if you require that analysis, you can continue to work with IBM directly.
After library preparation, denature and dilute libraries to the appropriate loading concentration using the instructions for standard normalized libraries.
Afters sequencing, choose a kit-specific analysis option.
|TruSight Tumor 170 BaseSpace App||TruSight Tumor 170 BaseSpace App Documentation|
|TruSight Tumor 170 + Watson for Genomics Converter||TruSight Tumor 170 + Watson for Genomics Converter App Documentation|
|TruSight Tumor 170 Local App||TruSight Tumor 170 Local App Documentation|